Alice Soragni

Title: The Innovative Contributions of Alice Soragni

Introduction

Alice Soragni is a prominent inventor based in Los Angeles, California. She has made significant strides in the field of cancer therapeutics, particularly through her innovative work on peptide inhibitors. With a total of two patents to her name, Soragni is recognized for her contributions to medical science and research.

Latest Patents

Alice Soragni's latest patents focus on structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics. These inventions relate to inhibitory peptides or CPP inhibitors that specifically bind to p53 proteins exhibiting aberrant conformations, such as those that are aggregated or misfolded. The patents describe methods for using these inhibitors to treat subjects with tumors that comprise aggregated p53, aiming to inhibit amyloidogenic aggregation or restore the proper folding of the misfolded protein.

Career Highlights

Soragni's career is marked by her dedication to advancing cancer treatment methodologies. Her work at the University of California has positioned her as a key figure in the research community. She has been instrumental in developing innovative solutions that address critical challenges in cancer therapeutics.

Collaborations

Alice Soragni has collaborated with notable colleagues, including David S. Eisenberg and Lin Jiang. These partnerships have further enhanced her research and contributed to the development of her patented technologies.

Conclusion

Alice Soragni's innovative work in the field of cancer therapeutics exemplifies her commitment to improving patient outcomes through scientific research. Her patents represent a significant advancement in the understanding and treatment of cancer, showcasing her role as a leading inventor in this vital area of medicine.